BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IHC
3501
DELISTED
Independence Holding Company
IHC
| $39.8K | ﹤0.01% |
1,558
+321
| +26% | +$12K |
|
3502
CALL
Travelers Companies
TRV
$77.2B
| $39.7K | ﹤0.01% |
4
-226
| -98% | -$28.1K |
|
|
ITI
3503
DELISTED
Iteris, Inc.
ITI
| $39.7K | ﹤0.01% |
12,406
+6,899
| +125% | +$32.2K |
|
3504
First Business Financial Services
FBIZ
$601M
| $39.7K | ﹤0.01% |
2,560
+573
| +29% | +$13.1K |
|
|
TREC
3505
DELISTED
Trecora Resources
TREC
| $39.7K | ﹤0.01% |
6,664
+1,452
| +28% | +$9.22K |
|
|
PTVCB
3506
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $39.4K | ﹤0.01% |
2,865
+624
| +28% | +$9.29K |
|
|
BRG
3507
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $39.4K | ﹤0.01% |
7,069
+3,891
| +122% | +$40.4K |
|
|
CNR
3508
Core Natural Resources Inc
CNR
$4.64B
| $39.2K | ﹤0.01% |
10,621
+4,005
| +61% | +$31.7K |
|
3509
Ohio Valley Banc Corp
OVBC
$218M
| $39.1K | ﹤0.01% |
1,304
+283
| +28% | +$9.2K |
|
3510
OptimizeRx
OPRX
$165M
| $38.8K | ﹤0.01% |
4,279
+2,290
| +115% | +$21.7K |
|
3511
Protagonist Therapeutics
PTGX
$9.8B
| $38.7K | ﹤0.01% |
5,486
+3,397
| +163% | +$25.5K |
|
3512
Diageo
DEO
$52.8B
| $38.6K | ﹤0.01% |
304
+300
| +7,500% | +$45K |
|
|
CHMA
3513
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $38.6K | ﹤0.01% |
10,568
+6,597
| +166% | +$29.3K |
|
|
BELFB
3514
Bel Fuse Inc Class B
BELFB
$4.13B
| $38.5K | ﹤0.01% |
3,952
+515
| +15% | +$7.5K |
|
3515
Graham Corp
GHM
$1.3B
| $38.3K | ﹤0.01% |
2,971
+721
| +32% | +$12.5K |
|
3516
Global Water Resources
GWRS
$256M
| $38.3K | ﹤0.01% |
3,761
+2,045
| +119% | +$25.1K |
|
3517
Genesis Energy
GEL
$1.92B
| $38.3K | ﹤0.01% |
9,773
-9,555
| -49% | -$132K |
|
3518
Foster
FSTR
$404M
| $38.2K | ﹤0.01% |
3,092
+752
| +32% | +$12.3K |
|
|
ZEUS
3519
DELISTED
Olympic Steel
ZEUS
| $38.1K | ﹤0.01% |
3,685
+468
| +15% | +$6.28K |
|
|
BFIN
3520
DELISTED
BankFinancial
BFIN
| $38.1K | ﹤0.01% |
4,329
+959
| +28% | +$10.9K |
|
3521
AXT Inc
AXTI
$5.07B
| $38.1K | ﹤0.01% |
11,873
+2,689
| +29% | +$9.9K |
|
3522
Celsius Holdings
CELH
$7.28B
| $38.1K | ﹤0.01% |
27,156
+15,432
| +132% | +$27.2K |
|
|
ARA
3523
DELISTED
American Renal Associates Holdings, Inc
ARA
| $38K | ﹤0.01% |
5,751
+2,031
| +55% | +$17.7K |
|
3524
Entravision Communication
EVC
$820M
| $37.9K | ﹤0.01% |
18,672
+5,090
| +37% | +$10.7K |
|
3525
Resideo Technologies
REZI
$3.1B
| $37.9K | ﹤0.01% |
7,831
-25,046
| -76% | -$236K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.